Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
70.09Prev. Close
70.02Volume
3,497Total traded value
0.02 CrUpper Circuit
73.52Lower Circuit
66.52Fundamentals
| Market Cap | ₹259Cr |
| ROE | 40.16% |
| P/E Ratio(TTM) | -17.20 |
| EPS(TTM) | -4.07 |
| P/B Ratio | 0.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 41.14 |
| Book Value | -6.77 |
| Debt to Equity | -2.43 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Oxygenta Pharmaceutical
Oxygenta Pharmaceutical Limited operates by manufacturing various drugs, including pharmaceutical preparations and Organic Fine Chemicals, serving a broad segment of the healthcare industry. The organization is fundamentally value-driven, ensuring its growth and success are guided by its core principles and ethical conduct in all business operations. Reflecting its performance, the company's gross total income significantly increased by 27.99% during the financial year 2023-24.;
| Parent Organisation | Oxygenta Pharmaceutical |
| Managing Director | Dr. Sai Vankineni |
| BSE Symbol | 524636 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 70.13 | ||
| Neuland Laboratories | NA (0.00%) | 111.47 | ||
| Jubilant Pharmova | NA (0.00%) | 37.80 | ||
| Acutaas Chemicals | NA (0.00%) | 62.78 |